Luxembourg Institute of Health (CRP-Santé)

Glioblastoma-instructed microglia transition to heterogeneous phenotypic states with phagocytic and dendritic cell-like features in patient tumors and patient-derived orthotopic xenografts (2024) Yabo YA, Moreno-Sanchez PM, Pires-Afonso Y, Kaoma T, Nosirov B, Scafidi A, Ermini L, et al. Journal article Publisher Correction: Determinants of exposure to acrylamide in European children and adults based on urinary biomarkers: results from the “European Human Biomonitoring Initiative” HBM4EU participating studies (Scientific Reports, (2023), 13, 1, (21291), 10.1038/s41598-023-48738-6) (2024) F. Fernández S, Poteser M, Govarts E, Pardo O, Coscollà C, Schettgen T, Vogel N, et al. Journal article, Erratum Fluorophore-Labeled Pyrrolones Targeting the Intracellular Allosteric Binding Site of the Chemokine Receptor CCR1 (2024) Toy L, Huber M, Lee M, Bartolomé AA, Ortiz Zacarías NV, Nasser S, Scholl S, et al. Journal article Development of a NanoBRET Assay Platform to Detect Intracellular Ligands for the Chemokine Receptors CCR6 and CXCR1 (2024) Huber M, Wurnig SL, Moumbock AF, Toy L, Kostenis E, Alonso Bartolomé A, Szpakowska M, et al. Journal article Determinants of exposure to acrylamide in European children and adults based on urinary biomarkers: results from the “European Human Biomonitoring Initiative” HBM4EU participating studies (2023) F. Fernández S, Poteser M, Govarts E, Pardo O, Coscollà C, Schettgen T, Vogel N, et al. Journal article Lactate dehydrogenases promote glioblastoma growth and invasion via a metabolic symbiosis (2022) Guyon J, Fernandez-Moncada I, Larrieu CM, Bouchez CL, Pagano Zottola AC, Galvis J, Chouleur T, et al. Journal article Time Trends of Acrylamide Exposure in Europe: Combined Analysis of Published Reports and Current HBM4EU Studies (2022) Poteser M, Laguzzi F, Schettgen T, Vogel N, Weber T, Zimmermann P, Hahn D, et al. Journal article Trends of Exposure to Acrylamide as Measured by Urinary Biomarkers Levels within the HBM4EU Biomonitoring Aligned Studies (2000-2021) (2022) Poteser M, Laguzzi F, Schettgen T, Vogel N, Weber T, Murawski A, Schmidt P, et al. Journal article IL-33-induced metabolic reprogramming controls the differentiation of alternatively activated macrophages and the resolution of inflammation (2021) Faas M, Ipseiz N, Ackermann J, Culemann S, Grüneboom A, Schröder F, Rothe T, et al. Journal article The Luxembourg Parkinson's Study: A Comprehensive Approach for Stratification and Early Diagnosis (2018) Hipp G, Vaillant M, Diederich NJ, Roomp K, Satagopam VP, Banda P, Sandt E, et al. Journal article